Symbol="ALT"
AssetType="Common Stock"
Name="Altimmune Inc"
Description="Altimmune, Inc., a clinical-stage biopharmaceutical company, focuses on the development of intranasal vaccines, immunomodulatory therapies, and treatments for liver disease. The company is headquartered in Gaithersburg, Maryland."
CIK="1326190"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="910 CLOPPER ROAD, SUITE 201S, GAITHERSBURG, MD, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="156256000"
EBITDA="-87612664"
PERatio="None"
PEGRatio="0"
BookValue="3.403"
DividendPerShare="0"
DividendYield="0"
EPS="-1.77"
RevenuePerShareTTM="-0.002"
ProfitMargin="0"
OperatingMarginTTM="1115.62"
ReturnOnAssetsTTM="-0.281"
ReturnOnEquityTTM="-0.484"
RevenueTTM="-79000"
GrossProfitTTM="-70520000"
DilutedEPSTTM="-1.77"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.344"
AnalystTargetPrice="24.57"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="162.98"
PriceToBookRatio="2.585"
EVToRevenue="99.22"
EVToEBITDA="-3.792"
Beta="-0.083"
num_52WeekHigh="23.49"
num_52WeekLow="3.09"
num_50DayMovingAverage="3.984"
num_200DayMovingAverage="8.83"
SharesOutstanding="49292200"
DividendDate="2018-09-14"
ExDividendDate="2017-01-20"
symbol="ALT"
open="3.23"
high="3.23"
low="3.09"
price="3.14"
volume="1171208.00"
latest_trading_day="2023-07-21"
previous_close="3.18"
change="-0.04"
change_percent="-1.2579%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="80"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Trending High"
value_analysis="Bullish Trend"
Aroon_change="FALSE"
Aroon_momentum="20"
Volume_recent_avg="2140498"
Change_recent_avg="-0.06"
Delta_recent_avg="0.36"
Variance_recent_avg="0.18"
Change_ratio_recent_avg="-1.38"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="20"
Aroon_momentum_negative="80"
image_negative_thumbnail_id_1="120"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0056.jpeg"
image_negative_thumbnail_id_2="1135"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0168.jpeg"
image_neutral_thumbnail_id_1="528"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0071.jpeg"
image_neutral_thumbnail_id_2="525"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0074.jpeg"
image_positive_thumbnail_id_1="698"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0010.jpeg"
image_positive_thumbnail_id_2="955"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0117.jpeg"
image_professor_thumbnail_id_1="1200"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0034.jpeg"
image_professor_thumbnail_id_2="1179"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0013.jpeg"
